Biogen Idec, Inc. (Massachusetts) Increases Revenue 6 Percent to $1.4 Billion in the Third Quarter

WESTON, Mass.--(BUSINESS WIRE)--Biogen Idec Inc. (NASDAQ: BIIB) today announced third quarter 2012 financial results, delivering revenue growth of 6 percent to $1.4 billion and non-GAAP diluted Earnings Per Share (EPS) growth of 19 percent.